News and Reports
Jacobin: How Big Pharma Turned FDA Approval Into a Rubber Stamp
Drug company employees with titles like “director of patient engagement” carefully cultivate relationships with advocacy groups. Some patient groups are led by executives on “loan” from industry, according to a study published in 2020, and nearly 40 percent have a pharmaceutical executive on their boards. Another study, by Patients for Affordable Drugs, the rare advocacy group that does not […]